Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 22 | 22 | 29 | 15 | 9 | 7 | 5 | 5 | 5 | 5 | | 5 |
% Growth | NA | 3.7% | 28.1% | -49.3% | -34.6% | -28.8% | -19.1% | -1.7% | -5.0% | 4.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (20) | (20) | (25) | (13) | (9) | (7) | (6) | (7) | (6) | (6) | | (6) |
Gross Profit | 2 | 2 | 3 | 2 | 0 | (1) | (1) | (2) | (1) | (1) | | (1) |
% Revenue | 9.2% | 11.1% | 12.1% | 10.7% | 0.9% | -8.4% | -15.4% | -30.6% | -17.4% | -11.4% | | -16.3% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | | (0) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (1) | (1) | (1) | (1) | (1) | (0) | (0) | (0) | (0) | (0) | | (0) |
Other Inc / (Exp) | (1) | (1) | (2) | (2) | (4) | (3) | (0) | (1) | (1) | (0) | | (0) |
Total Operating Exp | (2) | (2) | (3) | (3) | (4) | (3) | (1) | (1) | (1) | (1) | | (1) |
| | | | | | | | | | | | |
Operating Income | (0) | 1 | 0 | (1) | (4) | (4) | (1) | (3) | (2) | (1) | | (1) |
% Revenue | -1.2% | 2.6% | 0.1% | -7.7% | -42.9% | -52.7% | -24.8% | -49.7% | -43.2% | -22.5% | | -27.9% |
| | | | | | | | | | | | |
Interest Expense | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | | (0) |
Pre-tax Income | (0) | 0 | (0) | (1) | (4) | (4) | (2) | (3) | (2) | (2) | | (2) |
Earnings of Discontinued Ops. | 0 | (0) | (0) | (1) | (1) | (1) | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (0) | (0) | | (0) |
Net Income to Company | (1) | 0 | (1) | (2) | (6) | (5) | (1) | (3) | (2) | (2) | | (2) |
% Margin | -4.3% | 0.8% | -2.0% | -17.0% | -58.2% | -70.8% | -26.1% | -52.5% | -47.9% | -28.4% | | -35.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | (0) | (0) | 0 | (0) | 1 | 1 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (1) | 0 | (1) | (2) | (6) | (4) | (1) | (3) | (2) | (1) | | (2) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 1 | 1 | 1 | (0) | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (1) | 0 | (1) | (1) | (4) | (4) | (1) | (3) | (2) | (1) | | (2) |
% Margin | -4.3% | 1.3% | -2.0% | -9.5% | -45.3% | -52.6% | -17.6% | -50.6% | -46.7% | -27.7% | | -33.7% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.08) | 0.03 | (0.05) | (0.12) | (0.38) | (0.32) | (0.09) | (0.24) | (0.21) | (0.13) | | (0.15) |
Diluted EPS (Continuing Ops) | (0.09) | 0.03 | (0.05) | (0.13) | (0.38) | (0.32) | (0.09) | (0.24) | (0.21) | (0.13) | | (0.15) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | | 11.18 |
WA Diluted Shares Out. | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | 11.18 | | 11.18 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (0) | 0 | (0) | (1) | (4) | (4) | (2) | (3) | (2) | (2) | | (2) |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Non Operating Expenses, Total | (0) | (0) | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (0) | | (0) |
Addback: Depreciation & Amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (0) | (1) | (0) | 0 | (0) | 0 | (1) | (0) | (0) | (0) | | (0) |
Adjusted EBITDA | 0 | 1 | 1 | (0) | (2) | (1) | (1) | (2) | (1) | (1) | | (1) |
% Margin | 0.5% | 2.6% | 3.8% | -3.2% | -16.7% | -14.1% | -20.0% | -36.0% | -22.5% | -16.0% | | -20.6% |
| | | | | | | | | | | | |
Adjusted EBIT | (0) | (0) | 0 | (1) | (2) | (2) | (2) | (2) | (2) | (1) | | (1) |
% Margin | -1.8% | -0.6% | 0.3% | -7.7% | -24.3% | -29.2% | -34.4% | -43.4% | -30.0% | -24.2% | | -29.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (1) | 0 | (1) | (2) | (6) | (5) | (1) | (3) | (2) | (2) | | (2) |
Addback: Unusual Items | (0) | (1) | 0 | 0 | 2 | 2 | (0) | 0 | 1 | (0) | | (0) |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | (0) | (0) | (0) | (0) | 0 | (0) | (0) | 0 | | 0 |
Adjusted Net Income | (1) | (0) | (0) | (2) | (4) | (4) | (2) | (2) | (2) | (2) | | (2) |
% Margin | -4.3% | -1.5% | -1.7% | -16.9% | -44.1% | -53.4% | -32.7% | -46.2% | -37.4% | -29.7% | | -35.1% |